Total Quarterly Revenue Rises 55% Sequentially to
Enterprise Orders Increase 45% as Virtuix Expands Robotics, Defense, and Healthcare Applications
Company Enters into Non-Binding Letter of Intent to
Key Second Quarter Fiscal 2027 Results and Subsequent Highlights
- Revenue Growth:
Omni One revenue increased 105% to$1.1 million , while total revenue increased 21% year-over-year and 55% sequentially to$1.2 million .Omni One revenue, representing 93% of total revenue, was partially offset by a$0.3 million decline in legacyOmni Arena revenue. - Omni One Momentum: The number of
Omni One unit orders increased 3.3X year-over-year following theJune 2026 launch ofOmni One for Quest in collaboration with Meta.Virtuix has since become an official Meta reseller, launched bundles withMeta Quest 3 and Quest 3S headsets, and expanded its library to more than 75 compatible or upcoming Quest titles. - Enterprise Adoption: Omni One Enterprise orders increased 45% year-over-year, including repeat orders from Tesla for its Optimus humanoid robot program and a first order from
Figure AI , following prior sales to NASA, KBR, Sirica Therapeutics, and research institutions. - Proposed Acquisition of
STS International : Signed a non-binding letter of intent (“LOI”) to acquire all of the outstanding equity interests ofSTS International Inc. (“STS”), anArlington, Virginia -based defense technology and services company, for base consideration of approximately$12 million , plus potential earnout payments and other additional consideration. STS has advised the Company that it generated approximately$40 million in unaudited, cash-basis revenue for the 10 months endedOctober 31, 2026 . - Expanding Government Customer Base: Sold
Omni One systems to theU.S . Army’s Training Innovation Facility at Fort Leavenworth and theU.S . Navy’s Morale, Welfare and Recreation Liberty Program. Marine Corps Programs: Advanced the four-person Infantry Fireteam Trainer as lead systems integrator with KBR and AVRT, and showcased its counter-drone training platform, developed with LeadTech, at theManeuver Warfighter Conference .U.S . Air Force SBIR: Following its selection inMay 2026 for Phase I funding under theU.S . Air Force’sAFWERX Small Business Innovation Research (“SBIR”) program to advance development of the Virtual Terrain Walk (“VTW”) platform,Virtuix is preparing to submit a proposal for Phase II funding.- Healthcare Expansion: Sold its first
Omni One systems to theU.S. Department of Veterans Affairs for the Valor Center at theDetroit VA Medical Center .The LP Foundation also joined Sirica Therapeutics in Virtuix’s autism therapy initiative, with a multi-site pilot scheduled to begin in early 2027. - Intellectual Property: Secured its 27th
U.S . patent, covering proprietary footwear technology, with five additional patents pending.
Management Commentary
“Our second quarter demonstrates that
“At the same time, we are advancing our strategy to build a scaled defense technology and services business. Our proposed acquisition of
“Our priorities are clear: convert growing demand into revenue, expand higher-margin Enterprise opportunities, pursue larger defense programs, complete the proposed acquisition subject to its conditions, and reduce operating costs as we drive toward profitability,” concluded Mr. Goetgeluk.
“As we continue to scale
Second Quarter Financial Results
Net sales for the three months ended
Gross profit increased 30% sequentially to
Total operating expenses were
Total other expense, net, was
Net loss was
Adjusted EBITDA loss, a non-GAAP financial measure, was
Cash and cash equivalents totaled
As previously disclosed, prior-period amounts have been revised to correct immaterial errors related to the accounting for certain financing arrangements.
Proposed Acquisition of
As previously announced on
The proposed transaction remains subject to, among other things, satisfactory completion of due diligence, an audit of STS International’s financial statements,
The parties currently intend to complete due diligence, execute definitive agreements, and close the proposed transaction during Virtuix’s fiscal year ending
Second Quarter Fiscal Year 2027 Financial Results Conference Call
Virtuix Founder, Chief Executive Officer, and Chairman
To access the call, please use the following information:
Date:
Time:
International dial-in: 1-201-389-0878
Conference ID: 13763588
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1781164&tp_key=cbbdd7e49e
A telephone replay will be available approximately three hours after the call and will run through
Note About Non-GAAP Financial Measures
EBITDA and Adjusted EBITDA are non-GAAP financial measures. The Company defines EBITDA as net loss adjusted to exclude provision for (benefit from) income taxes, interest expense, net, and depreciation and amortization. The Company defines Adjusted EBITDA as net loss adjusted to exclude: (i) provision for (benefit from) income taxes, (ii) interest expense, net, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) financing expense, (vi) gains or losses on extinguishment of debt, and (vii) gains or losses from changes in the fair value of financial instruments. EBITDA and Adjusted EBITDA are not calculated in accordance with
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||
| Reconciliation of GAAP net loss to Adjusted EBITDA | ||||||||||||||||
| NET LOSS | $ | (6,367,511 | ) | $ | (1,866,696 | ) | $ | (13,538,077 | ) | $ | (4,173,851 | ) | ||||
| Plus: | ||||||||||||||||
| Taxes | 24,812 | 753 | 74,203 | 24,171 | ||||||||||||
| Interest expense, net(1) | 2,047,733 | 331,345 | 4,587,162 | 450,459 | ||||||||||||
| Depreciation and amortization | 159,576 | 157,006 | 302,529 | 315,782 | ||||||||||||
| EBITDA | $ | (4,135,390 | ) | $ | (1,377,592 | ) | $ | (8,574,183 | ) | $ | (3,383,439 | ) | ||||
| Plus: | ||||||||||||||||
| Stock-based compensation(2) | 1,040,608 | 205,588 | 1,763,545 | 216,485 | ||||||||||||
| Financing expense(3) | 426,249 | - | 1,010,399 | - | ||||||||||||
| Loss (gain) on extinguishment of debt | (37,492 | ) | - | 393,732 | 122,864 | |||||||||||
| Less: | ||||||||||||||||
| Change in fair value of financial instruments | (931,174 | ) | - | (1,303,524 | ) | - | ||||||||||
| ADJUSTED EBITDA | $ | (3,637,199 | ) | $ | (1,172,004 | ) | $ | (6,710,031 | ) | $ | (3,044,090 | ) | ||||
(1) Interest expense for the three and six months ended
(2) Stock-based compensation expense for the three and six months ended
(3) Financing expense represents non-cash charges recognized in connection with amendments to certain outstanding warrants during the three and six months ended
About Virtuix
Virtuix Holdings Inc. (NASDAQ: VTIX) is a leading developer of immersive, full-body immersive simulation systems and the creator of the “Omni” omni-directional treadmill. Virtuix’s technology lets users physically move through virtual and AI-generated environments. The Company’s products are deployed across consumer entertainment, defense training and simulation, robotics, healthcare, research, and enterprise applications involving organizations including Meta, NASA, Tesla, KBR, and Sirica Therapeutics. The Company’s growing federal and defense footprint includes programs, deployments, and research initiatives involving the U.S. Army, Marine Corps, Navy, and Air Force.
Virtuix continues to expand the Omni brand from immersive entertainment into a broader, full-body simulation technology platform serving multiple commercial and government markets. For more information, visit virtuix.com or the Company’s new Investor Relations website at invest.virtuix.com.
Cautionary Note Regarding Forward-Looking Statements
This press release, the related conference call, and the accompanying presentation contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” “could,” “would,” “potential,” “continue,” “focused,” “plans to,” “seek to,” “goal,” “target,” “vision,” “envision,” “objective,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding: the Company’s ability to convert order growth and its marketing investments, including its 2026 holiday sales funnel, into revenue; expectations regarding the Meta collaboration, the Company’s status as an official Meta reseller, its consumer bundles, and its library of compatible or upcoming Quest titles; the Company’s path to profitability, including expectations regarding sales mix, gross margin, and cash burn; the Company’s plans to streamline its cost structure, including in the areas of accounting, investor relations, and operational overhead; the Company’s liquidity, its need for additional financing, and its ability to regain compliance with Nasdaq’s continued listing requirements; the proposed acquisition of STS International, including the expected terms, structure, consideration, financing, timing, and completion of the transaction, the anticipated benefits of the transaction, the Company’s plans to establish Virtuix Defense, and the Company’s belief that STS International’s contracts and capabilities could accelerate sales of Virtual Terrain Walk, Infantry Fireteam Trainer, and other Omni-based training systems across the U.S. military and federal government, and the expected employment or consulting arrangement of STS International’s President, his expected role in leading Virtuix Defense, and his appointment to the Company’s Board of Directors; expectations regarding government programs and opportunities, including the Company’s planned proposal for AFWERX SBIR Phase II funding, the development of the Infantry Fireteam Trainer, and the Company’s counter-drone training platform; the Company’s programs, sales, and initiatives involving the U.S. Army, U.S. Marine Corps, U.S. Navy, U.S. Air Force, and U.S. Department of Veterans Affairs; expectations regarding enterprise and robotics applications, including future orders from Tesla, Figure AI, and other enterprise customers; expectations regarding healthcare and therapeutic applications, including the multi-site autism therapy pilot scheduled to begin in early 2027; the Company’s pending patent applications; and the Company’s position in and prospects for the consumer, defense, enterprise, and healthcare markets.
Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to: the Company’s ability to convert orders into revenue; the Company’s history of net losses and its need for additional financing to fund its planned operations over the next 12 months, and its ability to obtain financing on acceptable terms or at all; the substantial doubt regarding the Company’s ability to continue as a going concern; risks related to the Company’s pre-paid purchase arrangements with Streeterville Capital, LLC, including the occurrence of trigger events, potential substantial dilution to stockholders, the potential requirement to make cash payments if the purchase price remains below the $2.00 floor price for six consecutive months, which could occur as early as late January 2027, and the Company’s current inability to obtain additional pre-paid purchases; the Company’s ability to regain compliance with The Nasdaq Global Market’s minimum market value of listed securities requirement by March 29, 2027, and the potential consequences of a delisting, including a potential event of default and acceleration of amounts owed under the pre-paid purchase arrangements; the material weakness identified in the Company’s internal control over financial reporting related to the accounting for complex financing transactions, which resulted in revisions to previously reported financial information, and the Company’s ability to remediate it; the long sales cycle in the defense market and the risk that meaningful sales in the defense sector may not materialize until fiscal year 2028 at the earliest, if at all; the non-binding nature of the LOI and the risk that the parties do not enter into definitive agreements or that the proposed acquisition of STS International is not completed on the terms described, within the anticipated timeframe, or at all, including due to the results of due diligence or the financial audit, the Company’s inability to obtain financing for the cash portion of the consideration (for which it has no committed financing), or the failure to obtain required approvals, consents, or a fairness opinion; transaction costs the Company will incur whether or not the proposed acquisition is completed; dilution resulting from the issuance of Class A common stock in the proposed acquisition, including any additional shares issuable under stock-price protection or earnout provisions; the unaudited, cash-basis nature of the financial information of STS International, which was provided by STS International, has not been verified by the Company, and may differ materially from audited financial statements prepared in accordance with GAAP; the ability to successfully integrate any acquired business; risks related to government contracting, including procurement timelines, contract cancellations, modifications, or funding changes; uncertainties regarding the timing and success of defense program proposals, milestones, evaluations, pilot programs, and deployments; the Company’s dependence on its relationship with Meta and on consumer demand for Omni One; the Company’s ability to achieve market acceptance in new markets and applications; risks related to partnerships and collaborations with third parties; tariffs and other trade measures affecting products manufactured in China and imported into the United States; competition in the virtual reality, defense training, and simulation markets; and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2026, as updated by Part II, Item 1A of the Company’s Quarterly Reports on Form 10-Q for the quarters ended June 30, 2026 and September 30, 2026, and in the Company’s other filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release or made during the related conference call or in the accompanying presentation. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof, except as required by law.
Visit Us on Social Media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X
Company Contact
Lauren Premo
Virtuix Inc.
press@virtuix.com
Investor Relations Contact
Chris Tyson
MZ Group
Direct: 949-491-8235
VTIX@mzgroup.us
CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS | ||||||||
2026 | 2026 (As Revised) | |||||||
| CURRENT ASSETS | ||||||||
| Cash and cash equivalents | $ | 4,963,127 | $ | 9,471,288 | ||||
| Receivables, net of allowance for credit losses | 419,899 | 379,289 | ||||||
| Inventory | 1,672,155 | 1,188,623 | ||||||
| Prepaids and other current assets | 740,469 | 897,109 | ||||||
| TOTAL CURRENT ASSETS | 7,795,650 | 11,936,309 | ||||||
| NONCURRENT ASSETS | ||||||||
| Property and equipment | 1,418,811 | 1,413,294 | ||||||
| Less: accumulated depreciation | (1,113,622 | ) | (1,034,984 | ) | ||||
| Net property and equipment | 305,189 | 378,310 | ||||||
| Intangibles | 2,809,629 | 2,797,741 | ||||||
| Less: accumulated amortization | (1,481,744 | ) | (1,258,387 | ) | ||||
| Net intangibles | 1,327,885 | 1,539,354 | ||||||
| Investment in joint venture | - | 40,619 | ||||||
| Other assets | 61,169 | 87,264 | ||||||
| Right-of-use asset - operating | 622,370 | 779,514 | ||||||
| TOTAL NONCURRENT ASSETS | 2,316,613 | 2,825,061 | ||||||
| TOTAL ASSETS | $ | 10,112,263 | $ | 14,761,370 | ||||
| LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | ||||||||
2026 | 2026 (As Revised) | |||||||
| CURRENT LIABILITIES | ||||||||
| Accounts payable | $ | 663,625 | $ | 721,792 | ||||
| Accrued expenses | 836,572 | 559,517 | ||||||
| Deferred revenue | 652,612 | 666,327 | ||||||
| Gift card liability | 439,144 | 446,252 | ||||||
| Current portion of notes payable, net of discount and unamortized deferred loan costs | 8,207,781 | 5,328,477 | ||||||
| Notes payable measured under the fair value option – PPP #2 | 3,610,158 | - | ||||||
| Derivative liabilities at fair value | 1,233,095 | 2,709,817 | ||||||
| Current portion of EIDL loan | 581 | 570 | ||||||
| Lease liability - operating | 219,202 | 286,702 | ||||||
| TOTAL CURRENT LIABILITIES | 15,862,770 | 10,719,454 | ||||||
| LONG-TERM LIABILITIES | ||||||||
| Notes payable, net of discount and unamortized deferred loan costs | - | 2,428,835 | ||||||
| EIDL loan | 23,177 | 23,517 | ||||||
| Lease liability, net of current portion - operating | 403,168 | 492,812 | ||||||
| TOTAL LONG-TERM LIABILITIES | 426,345 | 2,945,164 | ||||||
| TOTAL LIABILITIES | 16,289,115 | 13,664,618 | ||||||
| STOCKHOLDERS’ (DEFICIT) EQUITY | ||||||||
| Class A common stock, | 30,602 | 28,562 | ||||||
| Class B common stock, | 4,000 | 4,000 | ||||||
| Additional paid-in capital | 86,673,058 | 80,410,625 | ||||||
| Accumulated deficit | (92,884,512 | ) | (79,346,435 | ) | ||||
| TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY | (6,176,852 | ) | 1,096,752 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | $ | 10,112,263 | $ | 14,761,370 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED | ||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| 2026 | 2025 (As Revised) | 2026 | 2025 (As Revised) | |||||||||||||
| $ | 1,190,097 | $ | 984,812 | $ | 1,957,397 | $ | 2,016,948 | |||||||||
| COST OF GOODS SOLD | 894,898 | 577,263 | 1,435,040 | 1,433,322 | ||||||||||||
| GROSS PROFIT | 295,199 | 407,549 | 522,357 | 583,626 | ||||||||||||
| OPERATING EXPENSES | ||||||||||||||||
| Selling expenses | 924,457 | 345,791 | 1,663,435 | 1,395,449 | ||||||||||||
| General and administrative expenses | 4,005,950 | 1,407,057 | 7,086,728 | 2,366,449 | ||||||||||||
| Research and development expenses | 202,248 | 189,469 | 511,623 | 398,185 | ||||||||||||
| TOTAL OPERATING EXPENSES | 5,132,655 | 1,942,317 | 9,261,786 | 4,160,083 | ||||||||||||
| LOSS FROM OPERATIONS | (4,837,456 | ) | (1,534,768 | ) | (8,739,429 | ) | (3,576,457 | ) | ||||||||
| OTHER INCOME (EXPENSE) | ||||||||||||||||
| Loss on disposal of assets | - | - | (5,132 | ) | - | |||||||||||
| Interest income | 87 | 114 | 250 | 299 | ||||||||||||
| Other income | 73 | 170 | 9,075 | 170 | ||||||||||||
| Gain (loss) on extinguishment of debt | 37,492 | - | (393,732 | ) | (122,864 | ) | ||||||||||
| Loss on derecognition of equity method investment | - | - | (40,619 | ) | - | |||||||||||
| Change in fair value of derivative liabilities | 667,554 | - | 1,016,682 | - | ||||||||||||
| Change in fair value of debt | 263,620 | - | 286,842 | - | ||||||||||||
| Interest expense | (2,047,820 | ) | (331,459 | ) | (4,587,412 | ) | (450,758 | ) | ||||||||
| Financing expense | (426,249 | ) | - | (1,010,399 | ) | - | ||||||||||
| TOTAL OTHER EXPENSE, NET | (1,505,243 | ) | (331,175 | ) | (4,724,445 | ) | (573,153 | ) | ||||||||
| PROVISION FOR INCOME TAX | 24,812 | 753 | 74,203 | 24,171 | ||||||||||||
| SHARE OF LOSS IN JOINT VENTURE | - | - | - | (70 | ) | |||||||||||
| NET LOSS | $ | (6,367,511 | ) | $ | (1,866,696 | ) | $ | (13,538,077 | ) | $ | (4,173,851 | ) | ||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic and Diluted | 33,913,262 | 21,588,700 | 33,353,686 | 14,964,525 | ||||||||||||
| Net loss per share: | ||||||||||||||||
| Basic and Diluted | $ | (0.19 | ) | $ | (0.09 | ) | $ | (0.41 | ) | $ | (0.28 | ) | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED | ||||||||
| Six Months Ended | ||||||||
| 2026 | 2025 (As Revised) | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net loss | $ | (13,538,077 | ) | $ | (4,173,851 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization expense | 302,529 | 315,782 | ||||||
| Amortization of debt discounts and debt issuance costs | 4,140,678 | 235,213 | ||||||
| Credit loss expense | 14,259 | 49,755 | ||||||
| Amortization on operating lease right of use asset | 157,144 | 142,120 | ||||||
| Stock-based compensation | 1,446,185 | 21,850 | ||||||
| Change in fair value of derivative liabilities | (1,016,682 | ) | - | |||||
| Change in fair value of debt | (286,842 | ) | - | |||||
| Loss on disposal of assets | 5,132 | - | ||||||
| Inventory write-offs | 8,109 | - | ||||||
| Loss on derecognition of the equity method investment | 40,619 | - | ||||||
| Share of loss in joint venture | - | 70 | ||||||
| Warrant modification expense | 1,010,399 | - | ||||||
| Loss on extinguishment of debt | 393,732 | 122,864 | ||||||
| Stock issuance in exchange for services | 317,360 | 194,635 | ||||||
| (Increase) decrease in assets: | ||||||||
| Prepaid expenses and other current assets | 222,014 | (305,033 | ) | |||||
| Accounts receivable | (54,869 | ) | (157,990 | ) | ||||
| Other assets | 26,095 | (98,890 | ) | |||||
| Inventory | (491,449 | ) | 323,466 | |||||
| Increase (decrease) in liabilities: | ||||||||
| Accounts payable | (58,167 | ) | 330,065 | |||||
| Accrued expenses | 682,592 | 80,181 | ||||||
| Gift card liability | (7,108 | ) | 456,552 | |||||
| Operating lease liabilities | (157,144 | ) | (142,120 | ) | ||||
| Deferred revenue | (13,715 | ) | (1,031,358 | ) | ||||
| CASH USED IN OPERATING ACTIVITIES | (6,857,206 | ) | (3,636,689 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Cash paid for purchases of property and equipment | (11,375 | ) | (20,388 | ) | ||||
| Cash paid for purchases of intangibles | (11,888 | ) | (2,192 | ) | ||||
| CASH USED IN INVESTING ACTIVITIES | (23,263 | ) | (22,580 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Issuance of preferred stock | - | 1,945,352 | ||||||
| Payments on short-term notes payable | (9,326 | ) | (443,186 | ) | ||||
| Payments on long-term notes payable | (329 | ) | (271 | ) | ||||
| Proceeds from short-term notes payable | - | 217,678 | ||||||
| Proceeds from convertible notes | - | 2,000,000 | ||||||
| Due (to) from related parties | - | 23,896 | ||||||
| Warrants exercised | 2,561,250 | 2,459 | ||||||
| Equity issuance costs | (179,287 | ) | - | |||||
| CASH PROVIDED BY FINANCING ACTIVITIES | 2,372,308 | 3,745,928 | ||||||
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (4,508,161 | ) | 86,659 | |||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 9,471,288 | 477,908 | ||||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | $ | 4,963,127 | $ | 564,567 | ||||
Source: